JP Patent

JP6260967B2 — 放射性ヨウ素標識化合物、及び、これを含む放射性医薬

Assigned to Nihon Medi Physics Co Ltd · Expires 2018-01-17 · 8y expired

What this patent protects

Patent listed against Itovebi.

Drugs covered by this patent

Patent Metadata

Patent number
JP6260967B2
Jurisdiction
JP
Classification
—
Expires
2018-01-17
Drug substance claim
No
Drug product claim
No
Assignee
Nihon Medi Physics Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.